Dr. Mohd Faheem Khan | Drug Design and Discovery | Outstanding Scientist Award

Dr. Mohd Faheem Khan | Drug Design and Discovery | Outstanding Scientist Award

Dr. Mohd Faheem Khan is a dedicated researcher, educator, and innovator in the field of chemistry with a strong background in natural products, phytochemistry, analytical sciences, and computational chemistry. He is currently serving as an Associate Professor in the Department of Biotechnology at Era University, Lucknow, where he teaches undergraduate, postgraduate, and doctoral courses. Over the years, he has contributed significantly to research on bioactive compounds from medicinal plants, green synthesis methods, and computational modeling. His academic journey, teaching experience, and scientific contributions demonstrate his commitment to advancing knowledge and mentoring future generations of scientists.

Era University, Lucknow |  India

Author Profiles

Scopus

Orcid

Education 

Dr. Mohd Faheem Khan holds a Ph.D. in Chemistry from Dr. RML Avadh University, Faizabad, India, where his doctoral thesis focused on “Phytochemical Investigation of Indian Medicinal Plants in search of Bioactive Compounds.” He carried out his research under the supervision of Dr. Rakesh Maurya, Chief Scientist, MPC Division, CDRI, Lucknow. Following this, he pursued Postdoctoral Research in Chemistry at HNB Garhwal University and Lucknow University, expanding his expertise in natural product chemistry and advanced molecular studies. He also completed his M.Sc. in Chemistry with first division from Lucknow University.

Teaching Experience

Dr. Khan is currently serving as an Associate Professor of Chemistry at the Department of Biotechnology, Era University, Lucknow. He teaches undergraduate, postgraduate, and Ph.D. coursework classes, contributing to the development of future scientists. Earlier, he worked as an Assistant Professor of Chemistry at Era University, where he actively taught and guided research activities. He has also served as a Postdoctoral Faculty Equivalent to Assistant Professor at Lucknow University and HNB Garhwal Central University, teaching both B.Sc. and M.Sc. courses, conducting practicals, and handling examination duties.

Research Experience

Dr. Khan is actively involved in teaching and research at the Department of Chemistry and Biotechnology, Era Medical College & Hospital, Era University, Lucknow. He worked as a Dr. D.S. Kothari Postdoctoral Research Fellow at Lucknow University under the mentorship of Prof. Sudha Jain, focusing on the synthesis of natural product-based receptors with anion recognition and transportation properties. At HNB Garhwal Central University, under Prof. D.S. Negi, he investigated herbal antidiabetic agents from unexplored plants of the Uttarakhand Himalaya. His early research experience includes roles as a Senior Research Fellow and Junior Research Fellow at the MPC Division, CDRI Lucknow, where he worked extensively on bioactive natural compounds. He also gained industry experience as a Trainee Research Associate at Jubilant Chemsys Pvt. Ltd., Noida, focusing on the synthesis of biologically important lead molecules.

Research Interests

Dr. Khan’s research spans multiple domains, with a strong focus on Natural Product Chemistry, Analytical Chemistry, and Computational Chemistry. His laboratory specializes in bioassay-guided extraction and isolation of secondary metabolites, structure elucidation using NMR, MS, and X-ray techniques, and quantification of marker compounds in herbal formulations through UHPLC, LC-MS/MS, and GC-MS/MS. He is also engaged in green chemistry approaches and nanotechnology for developing advanced herbal formulations. On the computational side, his expertise includes molecular docking, molecular dynamics simulation, pharmacophore modeling, DFT studies, and quantum theory of atoms applied to natural molecules.

Awards & Recognition

Dr. Khan has been honored with several prestigious awards, including the Global Scientist Award, the Best Oral Presentation Award, and the Best Speaker Award at scientific forums. He has been a recipient of the Dr. D.S. Kothari Postdoctoral Fellowship, as well as the CSIR-UGC Junior and Senior Research Fellowships, highlighting his strong academic and research credentials.

Memberships & Editorial Roles

Dr. Khan is an active member of various scientific societies and editorial boards. He is a Life Member of the Indian Society of Personalized Medicine, Association of Chemistry Teachers, Society for Ethnopharmacology, and Bioinformatics & Drug Discovery Society. He is also a Member of the American Chemical Society (ACS) and served as a Bentham Ambassador for India. Additionally, he has contributed as a Scientific Advisor for educational and research organizations. His editorial contributions include roles as Associate Editorial Board Member of Coronavirus Journal (Bentham Sciences), Editorial Board Member of the Online Journal of Chemistry, and Review Editor for Frontiers in Pharmacology.

Notable Publications

Zinc oxide nanoparticles (ZnONPs) from Manilkara hexandra leaves: biogenic synthesis, GC–MS analysis and antibacterial activity

Authors: Charul Somani; Pankaj Naharwal; Mohammad Faheem Khan; Vineet Kumar Maurya; Waseem Ahmad Ansari; Mohd Baqar Ali; Dinesh Kumar Yadav

Journal: Discover Chemistry

Year: 2025

UHPLC and Computational Studies of Chemical Constituents Derived from Myrica esculenta against NADPH Oxidase 2 (NOX2) Protein

Authors: Amit Ranjan Pandey; Waseem Ahmad Ansari; Priyanka Maurya; Hassan Aslam; Rishi Ranjan Pandey; Devendra Pratap Mishra; Safia Obaidur Rab; Saheem Ahmad; Paridhi Puri; Mohammad Faheem Khan

Journal: ChemistrySelect

Year: 2025

COF‐SO3H‐Catalyzed Synthesis of Pyrazoline‐Pyridine Hybrids with Dual Antioxidant and Anti‐Inflammatory Activity Targeting PDE4B

Authors: Nida Khan; Mohd Kamil Hussain; Mohammad Faheem Khan; Zeba N. Siddiqui

Journal: Chemistry & Biodiversity

Year: 2025

Computational screening of chemical constituents derived from berry fruits as allosteric caspase-3/-7 inhibitors

Authors: Waseem Ahmad Ansari; Mohsin Ali Khan; S. M. Mahfooz Hasan; Zainab Siddiqui; Saheem Ahmad; Mohd Shahnawaz Khan; Mohammad Faheem Khan

Journal: 3 Biotech

Year: 2024

An ultrasound assisted, ionic liquid-molecular iodine synergy driven efficient green synthesis of pyrrolobenzodiazepine-triazole hybrids as potential anticancer agents

Authors: Saquib, M.; Ahamad, S.; Khan, M.F.; Khan, M.I.; Hussain, M.K.

Journal: Frontiers in Pharmacology

Year: 2023

Different Variants of SARS-CoV-2: A Comprehensive Review on Mutation Patterns and Pathogenicity

Authors: Rizvi, F.; Khan, M.A.; Ansari, W.A.; Ali, K.; Khan, M.A.; Khan, M.F.

Journal: Coronaviruses

Year: 2023

Conclusion

Dr. Mohd Faheem Khan’s career reflects a blend of strong academic foundations, innovative research, and impactful teaching. His work in natural products and medicinal plant research has provided new insights into bioactive compounds, while his skills in analytical and computational chemistry strengthen his multidisciplinary approach. Through his teaching roles, he has contributed to shaping the next generation of chemists and biotechnologists. His numerous awards and professional memberships further demonstrate his recognition in the scientific community. With a commitment to research excellence and education, he continues to make meaningful contributions to the field of chemical and biological sciences.

Laxmi Tiwari | Medicinal Chemistry | Best Researcher Award

Dr. Laxmi Tiwari | Medicinal Chemistry | Best Researcher Award

Icahn School of Medicine at Mount Sinai, United States

Author Profiles

Scopus

Orcid

Google Scholar

🎓 Educational Background

Dr. Laxmi Tiwari is currently completing her Ph.D. in Chemistry with an impressive GPA of 3.98 at the University of Idaho, Moscow, ID (Aug 2021 – Dec 2024), under the mentorship of Assoc. Prof. Dr. Kristopher V. Waynant. Her research focuses on the “Synthesis and Applications of Azothioformamide and Azoformamide Ligands in Coordination, Catalysis, and Biological Activity.” She earned her M.S. in Chemistry from Tribhuvan University, Kathmandu, Nepal (May 2017 – July 2019), and completed her B.S. in Chemistry from the same institution (Aug 2012 – July 2016), laying a strong academic foundation in chemical sciences.

🧪 Professional Experience

Dr. Tiwari began her postdoctoral journey as a Research Assistant Scientist in January 2025 at the Pharmacological Department, Icahn School of Medicine at Mount Sinai, NY, under the guidance of Prof. Dr. Robert J. DeVita. Here, she is involved in designing and synthesizing organic molecules targeting diseases such as IBD, cancer, and diabetes. Her responsibilities include conducting clinical research, computational modeling, and developing new methodologies and instrumentation for medical applications. She actively contributes to research through hypothesis development, data evaluation, and publishing scientific findings, all while ensuring strict safety and contamination protocols are maintained. Previously, she served as a Graduate Research and Teaching Assistant at the University of Idaho (Aug 2021 – Dec 2024). Her work included retrosynthetic design, metal-ligand complex formation, and the development of palladium-catalyzed C–C and C–N coupling reactions. She also led efforts in drug synthesis, SAR analysis, and fluorescence sensing using heteroleptic cuprous complexes. She played a key role in student training, lab safety compliance, and instruction of both general and organic chemistry courses, including CHEM 101, 111, 112, 278, and 378.

🧠 Technical Skills & Expertise

Dr. Tiwari possesses advanced instrumentation skills, including NMR (1D & 2D), FT-IR, Mass Spectrometry, UV-Vis, SEM, and electrochemistry. She is proficient with software tools like ChemDraw, Topspin, Mnova, Schrodinger-Maestro, SwissADME, and AutoDock Vina. Her lab expertise includes flash column chromatography, crystallization, hazardous waste management, and more. She is also recognized for her problem-solving abilities, analytical thinking, communication skills, and attention to detail, all essential traits for thriving in complex research environments.

🏆 Awards & Honors

Dr. Tiwari has been honored with several prestigious awards including the ACS DIC Travel Award (Fall 2023), GPSA Travel Awards (2023 & 2024) from the University of Idaho, the Thomas F. Howland Award (2024), and the Cooley-Jube Outstanding TA Award (2024–2025). These recognitions reflect her academic excellence, research contributions, and dedication to teaching.

👩‍🔬 Professional Membership

She is an active member of the American Chemical Society (ACS) since 2021, which underscores her commitment to professional development and collaborative scientific advancement.

Notable Publications📝


📝Exploring Photocatalytic, Antimicrobial and Antioxidant Efficacy of Green-Synthesized Zinc Oxide Nanoparticles

Authors: Sabina Shrestha, Laxmi Tiwari, Sujan Dhungana, Jasana Maharjan, Devendra Khadka, Allison A. Kim, Megh Raj Pokhrel, Janaki Baral, Mira Park, Bhoj Raj Poudel

Journal: Nanomaterials

Year: 2025


📝Exploring the Electronic Influence on Coordination Complexes Formed from Appended Pyrrolidine Azothioformamide Ligands and Copper(I) Salts

Authors: Laxmi Tiwari, Zachariah M. Heiden, Kristopher V. Waynant

Journal: Journal of Molecular Structure

Year: 2025


📝Green Synthesis of Copper Oxide Nanoparticles Using Mentha (Mint) Leaves Characterization and Its Antimicrobial Properties with Phytochemicals Screening

Authors: Janaki Baral, Neena Pokharel, Sujan Dhungana, Laxmi Tiwari, Devendra Khadka, Megh Raj Pokhrel, Bhoj Raj Poudel

Journal: Journal of Nepal Chemical Society

Year: 2025


📝Synthesis and Characterization of Copper Oxide Nanoparticles Isolated from Acmella oleracea and Study of Antimicrobial and Phytochemical Properties

Authors: Sujan Dhungana, Anusa Gauli, Laxmi Tiwari, Devendra Khadka, Surendra Kumar Gautam, Megh Raj Pokhrel, Janaki Baral, Bhoj Raj Poudel

Journal: Amrit Research Journal

Year: 2024


📝Investigating Arylazoformamide Ligands in Palladium(II) Precatalysts through the Suzuki–Miyaura Cross-Coupling Reaction

Authors: Laxmi Tiwari, Elliott B. Hulley, Kristopher V. Waynant

Journal: The Journal of Organic Chemistry

Year: 2024

 

Dr. Aloïse Mabondzo | drug design | Best Researcher Award

Dr. Aloïse Mabondzo | drug design | Best Researcher Award

Doctorate at CEA, France

Professional Profiles

Google Scholar

Scopus

Orcid

🎓 Educational Background

Dr. Aloïse Mabondzo, has a distinguished academic foundation. He earned his Master’s degree in Molecular and Cellular Biology from the University of Strasbourg, France (1986-1989). Driven by a passion for cutting-edge research, he pursued a PhD in Virology and Immunology at the prestigious Pierre and Marie Curie University, France (1989-1993). His doctoral work focused on Active Immunotherapy using bispecific antibodies against HIV, a testament to his early commitment to tackling global health challenges.

🧪 Professional Positions

Dr. Mabondzo’s illustrious career began with a Post-doctoral Research Fellowship (1993-1997) at the CEA Neurovirology Department, where he made significant contributions to the field of neurovirology. In 1998, he joined the CEA Medicine and Healthcare Technologies Department, where he has served as Research Director and Head of the Neurovascular Unit Research and Therapeutic Innovation Laboratory. His leadership in these roles has driven breakthroughs in neurovascular research. Since 2019, Dr. Mabondzo has also been the Co-founder and Research Director of Ceres Brain Therapeutics, a startup dedicated to pioneering therapeutic innovations.

👩‍🏫 Mentoring and Supervision

Dr. Mabondzo has a proven track record as a mentor and supervisor. Over his career, he has supervised 16 PhD candidates (10 past, 6 current), 7 Postdoctoral Fellows (4 past, 3 current), and several other researchers, including 2 Research Assistants, 2 Engineers, and 2 Technicians. His mentorship has nurtured the next generation of scientists, fostering innovation and collaboration.

Publications Top Noted📄 

Dodecyl creatine ester therapy: from promise to reality

Authors: Mabondzo, A.; van de Kamp, J.; Mercimek-Andrews, S.

Journal: Cellular and Molecular Life Sciences

Year: 2024

A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases

Authors: Angeli, E.; Paris, J.; Le Tilly, O.; Paintaud, G.; Bousquet, G.

Journal: Experimental Hematology and Oncology

Year: 2024

Impaired brain glucose metabolism as a biomarker for evaluation of dodecyl creatine ester in creatine transporter deficiency: Insights from patient brain-derived organoids and in vivo [18F]FDG PET imaging in a mouse model

Authors: Disdier, C.; Soyer, A.; Broca-Brisson, L.; Tournier, N.; Mabondzo, A.

Journal: Neurobiology of Disease

Year: 2024

Targeting the Multiple Complex Processes of Hypoxia-Ischemia to Achieve Neuroprotection

Authors: Maïza, A.; Hamoudi, R.; Mabondzo, A.

Journal: International Journal of Molecular Sciences

Year: 2024

Epigenetic alterations in creatine transporter deficiency: a new marker for dodecyl creatine ester therapeutic efficacy monitoring

Authors: Broca-Brisson, L.; Disdier, C.; Harati, R.; Hamoudi, R.; Mabondzo, A.

Journal: Frontiers in Neuroscience

Year: 2024

Dr. Cesira Giordano, Medicinal Chemistry, Women Researcher Award

Dr. Cesira Giordano, Medicinal Chemistry, Women Researcher Award

Doctorate at Azienda Opedaliero-Universitaria Pisana, Italy

Professional Profiles

Scopus

Orcid

🎓 Education and Academic Background

Cesira Giordano, born on January 28, 1987, holds a Master’s Degree in Molecular Biology, with a specialization in Microbiology and Virology. She furthered her expertise by completing a 2nd level Master’s in OMIC Data Analysis, reflecting her commitment to integrating cutting-edge technology into her field.

🧑‍🔬 Professional Qualifications and Current Role

Since October 2019, Cesira has held a permanent position as a Biologist Manager at the Hospital Microbiology Department of Azienda Ospedaliero-Universitaria Pisana (AOUP) in Pisa. As a Clinical Microbiologist, she is responsible for key microbiological analyses, including regional control measures in line with Tuscany’s Decree No. 16286 of 2017. Cesira’s work ensures public health laboratories maintain their high standards, particularly through her role as the Single EQA (External Quality Assessment) contact person for SD Hospital Microbiology at AOUP.

🏆 Leadership in Public Health and Tender Commissions

Cesira has been actively involved in public health laboratory management, serving as a Tender Commissioner for various public health tenders in 2023 and 2024. Her roles include:

  • June 2024: Tender Commissioner for AOUP ESTAR, overseeing consumables and accessories for public health laboratories.
  • September 2023: Tender Commissioner for AOUP, focusing on microbiological identifications and antibiotic testing (Antibiograms).
  • July 2023–Ongoing: AOUP Contact Person for the Tuscany Region regarding communications about Listeria monocytogenes.

🔬 Research Contributions and Innovations

Cesira’s research focuses on the development and application of innovative microbiological technologies. Between 2018 and 2019, she was awarded a research grant to develop Fourier Transform Infrared Spectroscopy (FTIR) technology for identifying bacteria and yeast. This work, conducted in collaboration with the University of Pisa, has laid the groundwork for bacterial typing and investigating antibiotic resistance.

Her other research highlights include:

2018: Development of rapid antibiogram protocols for multi-organ donor samples, under the supervision of Dr. Simona Barnini.

2017: Analysis of the genomes of Klebsiella pneumoniae using Next Generation Sequencing (NGS) techniques. This project aimed at identifying new genes responsible for antibiotic resistance, carried out under the leadership of Dr. Simona Barnini.

🌍 International Research and Collaboration

In 2016, Cesira expanded her research experience internationally, spending time at the University Medical Center Groningen (UMCG), Netherlands. There, she worked on whole genome sequencing of multi-resistant Klebsiella pneumoniae strains, contributing to the understanding of antibiotic resistance mechanisms under the guidance of Prof. Dr. Alexander Friedrich, Dr. Erik Bathoorn, and Dr. John Rossen.

🧪 Pioneering Work in Microbiological Diagnostics

Cesira has made significant strides in rapid diagnostic methodologies. In 2016, she played a crucial role in developing rapid molecular and phenotypic antibiograms aimed at diagnosing sepsis swiftly. The protocols she helped develop reduced diagnostic time to as little as 3-6 hours after blood culture positivity, using advanced techniques like MALDI TOF MS. These advancements have greatly improved clinical response times in critical cases, saving lives.

Publications Top Noted📚

Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections

Authors: Shields, R.K., Dorazio, A.J., Tiseo, G., Doi, Y., Falcone, M.

Journal: JAC-Antimicrobial Resistance

Year: 2024

Glycine restores the sensitivity to antibiotics in multidrug-resistant bacteria

Authors: Giordano, C., Barnini, S.

Journal: Microbiology Spectrum

Year: 2024

Clinical Features and Outcomes of Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales: A 3-Year Prospective Study from an Endemic Area

Authors: Falcone, M., Giordano, C., Leonildi, A., Barnini, S., Tiseo, G.

Journal: Clinical Infectious Diseases

Year: 2024

Real-world experience with meropenem/vaborbactam for the treatment of infections caused by ESBL-producing Enterobacterales and carbapenem-resistant Klebsiella pneumoniae

Authors: Tiseo, G., Galfo, V., Riccardi, N., Barnini, S., Falcone, M.

Journal: European Journal of Clinical Microbiology and Infectious Diseases

Year: 2024

Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa

Authors: Lee, S.Y., Gill, C.M., Nicolau, D.P., Fang, F., Thomson, G.

Journal: Journal of Antimicrobial Chemotherapy

Year: 2023